Dominant expression of 85-kDa form of cortactin in colorectal cancer

Journal of Cancer Research and Clinical Oncology

Volumn 132, Issue 2, 2006, Pages 113-120

  Zhang, Lian Hai ^a   Tian, Bo ^b   Diao, Li Rong ^c   Xiong, Yong Yan ^d   Tia, Su Fang ^d   Zhang, Bian Hong ^c   Li, Wen Mei ^a   Ren, Hui ^a   Li, Ya ^d   Ji, Jia Fu ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b FUDAN UNIVERSITY   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^d WUHAN UNIVERSITY   (China)

Author keywords

Cell movement; Colorectal neoplasms; Cortactin; Gene expression

Indexed keywords

CORTACTIN; TUMOR MARKER;

ARTICLE; CANCER STAGING; CELL CULTURE; CELL MOTION; CHEMISTRY; COLORECTAL TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; LASER SURGERY; MALE; METHODOLOGY; MICRODISSECTION; MIDDLE AGED; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TIME;

CELL MOVEMENT; COLORECTAL NEOPLASMS; CORTACTIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LASER SURGERY; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM STAGING; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 33646978958     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-005-0046-8     Document Type: Article

References (29)

1. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC (1999) An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18:4440-4449 (Pubitemid 29396652)
2. Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE (1981) Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 41:1751-1756 (Pubitemid 11114567)
3. Campbell DH, Sutherland RL, Daly RJ (1999) Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res 59:5376-5385 (Pubitemid 29504008)
4. Cunningham CC (1992) Actin structural proteins in cell motility. Cancer Metastasis Rev 11:69-77
5. Diep CB, Parada LA, Teixeira MR, Eknaes M, Nesland JM, Johansson B, Lothe RA (2003) Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis. Genes Chromosomes Cancer 36:189-197 (Pubitemid 36109562)
6. Fantl V, Smith R, Brookes S, Dickson C, Peters G (1993) Chromosome 11q13 abnormalities in human breast cancer. Cancer Surv 18:77-94 (Pubitemid 24110634)
7. He QJ, Zeng WF, Sham JS, Xie D, Yang XW, Lin HL, Zhan WH, Lin F, Zeng SD, Nie D, Ma LF, Li CJ, Lu S, Guan XY (2003) Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genet Cytogenet 144:112-118 (Pubitemid 36808957)
8. Huang C, Liu J, Haudenschild CC, Zhan X (1998) The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem 273:25770-25776 (Pubitemid 28475803)
9. Huang C, Ni Y, Wang T, Gao Y, Haudenschild CC, Zhan X (1997) Down-regulation of the filamentous actin cross-linking activity of cortactin by Src-mediated tyrosine phosphorylation. J Biol Chem 272:13911-13915 (Pubitemid 27224834)
10. Knosel T, Petersen S, Schwabe H, Schluns K, Stein U, Schlag PM, Dietel M, Petersen I (2002) Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases. Virchows Arch 440:187-194 (Pubitemid 34169857)
11. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M, Zhan X (2001) Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 61:6906-6911 (Pubitemid 32896517)
12. Lynch DK, Winata SC, Lyons RJ, Hughes WE, Lehrbach GM, Wasinger V, Corthals G, Cordwell S, Daly RJ (2003) A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J Biol Chem 278:21805-21813 (Pubitemid 36792585)
13. Mayer R (1996) Gastrointestinal cancer. In: Dale DC, Federman DD (eds) Scientific American Medicine, vol 3. Scientific American, Inc., New York, pp 1-22
14. Meredith SD, Levine PA, Burns JA, Gaffey MJ, Boyd JC, Weiss LM, Erickson NL, Williams ME (1995) Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch Otolaryngol Head Neck Surg 121:790-794
15. Patel AS, Schechter GL, Wasilenko WJ, Somers KD (1998) Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16:3227-3232 (Pubitemid 28330420)
16. Peters G, Fantl V, Smith R, Brookes S, Dickson C (1995) Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat 33:125-135
17. Rinnerthaler G, Geiger B, Small JV (1988) Contact formation during fibroblast locomotion: involvement of membrane ruffles and microtubules. J Cell Biol 106:747-760 (Pubitemid 18089975)
18. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ (1992a) Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355-361
19. Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ, et al (1992b) Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 52:5229-5234
20. Tompkins WA, Watrach AM, Schmale JD, Schultz RM, Harris JA (1974) Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst 52:1101-1110
21. van Damme H, Brok H, Schuuring-Scholtes E, Schuuring E (1997) The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J Biol Chem 272:7374-7380 (Pubitemid 27166448)
22. Voura EB, Sandig M, Kalnins VI, Siu C (1998) Cell shape changes and cytoskeleton reorganization during transendothelial migration of human melanoma cells. Cell Tissue Res 293:375-387 (Pubitemid 28428378)
23. Weed SA, Karginov AV, Schafer DA, Weaver AM, Kinley AW, Cooper JA, Parsons JT (2000) Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol 151:29-40
24. Weed SA, Parsons JT (2001) Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 20:6418-6434 (Pubitemid 32977848)
25. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA (1993) Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg 119:1238-1243 (Pubitemid 23339141)
26. Winawer SJ, St John DJ, Bond JH, Rozen P, Burt RW, Waye JD, Kronborg O, O'Brien MJ, Bishop DT, Kurtz RC, et al (1995) Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ 73:7-10
27. Wu H, Parsons JT (1993) Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 120:1417-1426 (Pubitemid 23081688)
28. Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT (1991) Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 11:5113-5124 (Pubitemid 21895272)
29. Yuan BZ, Zhou X, Zimonjic DB, Durkin ME, Popescu NC (2003) Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma. J Mol Diagn 5:48-53 (Pubitemid 36193000)